Sun Pharmaceutical Sees 15,648 Contracts in 1540 Strike Price Puts Amid Market Decline

Sun Pharmaceutical Industries Ltd has emerged as one of the most active stocks in the options market today, particularly in the put options segment. The company, a significant player in the Pharmaceuticals & Biotechnology industry, has seen substantial trading activity in its put options with various strike prices set for expiry on September 30, 2025.
Notably, the put option with a strike price of 1580 recorded the highest trading volume, with 11,405 contracts exchanged, resulting in a turnover of approximately Rs 902.14 lakhs. Following closely, the strike price of 1540 saw 15,648 contracts traded, contributing Rs 754.16 lakhs to the turnover. Other notable strike prices included 1600, 1520, and 1500, with respective contracts traded of 7,066, 7,556, and 15,469.

The underlying value of Sun Pharma is currently at Rs 1595.00, having reached a new 52-week low of Rs 1548 today. The stock opened with a gap down of 2.61% and has underperformed its sector by 0.44%. With a one-day return of -2.35%, the stock is trading below its moving averages across various time frames, indicating a bearish trend. Despite this, there has been a notable increase in investor participation, with delivery volumes rising by 53.84% compared to the five-day average.

In summary, Sun Pharmaceutical Industries Ltd is experiencing significant activity in its put options, reflecting current market dynamics and investor behavior, while the stock itself faces challenges in performance metrics.